Citrix Server Upgrade
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), Office of Chief Scientist, Office of Analytical and Regulatory Labs (OARL), is seeking proposals for a Citrix Server Upgrade. This requirement involves provisioning Windows 2019 Servers to support Citrix Empower 3.6.1 Client and NuGenesis management client re-installations, replacing outdated Windows 2016 servers. The effort ensures continued function of the Chromatographic Data System (CDS) for laboratories in Irvine, CA; Detroit, MI; and Jamaica, NY. Quotes are due June 18, 2026, by 1:00 PM EST.
Scope of Work
The contractor will be responsible for:
- Migrating all current software components of Empower and NuGenesis to new servers.
- Ensuring the continued function of the Chromatographic Data System (CDS) for laboratory instruments.
- Providing deployment services for the installation of application servers.
- Performing Empower and NuGenesis quality testing, including Installation Qualification (IQ) and Operation Qualification (OQ).
- Conducting Regression Testing of Empower.
- Providing server requirements for the CDS software.
- Assisting with setup, installation, configuration, and qualification of the upgraded Citrix servers.
Contract & Timeline
- Type: Firm Fixed Price (FFP) Purchase Order
- Anticipated Period of Performance: One (1) twelve-month base year, starting from the date of award.
- Delivery: All items to be completed within 60 days of award.
- Set-Aside: Full and Open Competition
- Questions Due: June 10, 2026, by 1:00 PM Washington DC Local Time
- Quotes Due: June 18, 2026, by 1:00 PM EST
- Published: June 3, 2026
- Solicitation Number: FDA-75F40126Q00166
Evaluation
Award will be made on the basis of the Lowest Price Technically Acceptable (LPTA) evaluation method.
Additional Notes
Quoters must submit quotes via email to Tiffany Gates (tiffany.gates@fda.hhs.gov). Authorized reseller/servicing agent documentation is required. Quotes must clearly state license number, product description, quantity, price, and period of performance, and be certified valid for 60 days. The government is not obligated to make an award.